These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22645201)

  • 1. Short-term effects of GH treatment on coagulation, fibrinolysis, inflammation biomarkers, and insulin resistance status in prepubertal children with GH deficiency.
    Cañete R; Valle M; Martos R; Sánchez-Carrión A; Cañete MD; van Donkelaar EL
    Eur J Endocrinol; 2012 Aug; 167(2):255-60. PubMed ID: 22645201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of recombinant human growth hormone on glucose metabolism in children with growth hormone deficiency].
    Liang L; Zou CC; Li Y; Wang CL; Jiang YJ; Dong GP; Fu JF; Wang XM
    Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):657-61. PubMed ID: 17217656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial dysfunction is related to insulin resistance and inflammatory biomarker levels in obese prepubertal children.
    Valle Jiménez M; Estepa RM; Camacho RM; Estrada RC; Luna FG; Guitarte FB
    Eur J Endocrinol; 2007 Apr; 156(4):497-502. PubMed ID: 17389466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone-induced increases in skeletal muscle mass alleviates the associated insulin resistance in short children born small for gestational age, but not with growth hormone deficiency.
    Martin DD; Schweizer R; Schönau E; Binder G; Ranke MB
    Horm Res; 2009; 72(1):38-45. PubMed ID: 19571558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency.
    Deepak D; Daousi C; Javadpour M; Clark D; Perry Y; Pinkney J; Macfarlane IA
    Growth Horm IGF Res; 2010 Jun; 20(3):220-5. PubMed ID: 20185347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-sectional and prospective study of the effects of GH therapy on metabolic panel in children with GH deficiency.
    Ramistella V; Wasniewska M; Arasi S; Catena M; Velletri MR; Corica D; Santucci S; De Luca F
    Pediatr Med Chir; 2014 Dec; 36(5-6):104. PubMed ID: 25669895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic parameters and adipokine profile during GH replacement therapy in children with GH deficiency.
    Ciresi A; Amato MC; Criscimanna A; Mattina A; Vetro C; Galluzzo A; D'Acquisto G; Giordano C
    Eur J Endocrinol; 2007 Mar; 156(3):353-60. PubMed ID: 17322495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin sensitivity modulates the growth response during the first year of high-dose growth hormone treatment in short prepubertal children born small for gestational age.
    Gies I; Thomas M; Tenoutasse S; De Waele K; Lebrethon MC; Beckers D; Francois I; Maes M; Rooman R; de Beaufort C; Massa G; De Schepper J
    Horm Res Paediatr; 2012; 78(1):24-30. PubMed ID: 22832126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating asymmetric dimethylarginine and lipid profile in pre-pubertal children with growth hormone deficiency: effect of 12-month growth hormone replacement therapy.
    De Marco S; Marcovecchio ML; Caniglia D; De Leonibus C; Chiarelli F; Mohn A
    Growth Horm IGF Res; 2014 Oct; 24(5):216-20. PubMed ID: 25172154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum markers of GH and insulin action in 12-year-old children born small for gestational age.
    Tenhola S; Halonen P; Jääskeläinen J; Voutilainen R
    Eur J Endocrinol; 2005 Mar; 152(3):335-40. PubMed ID: 15757848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The exon 3-deleted/full-length growth hormone receptor polymorphism does not influence the effect of puberty or growth hormone therapy on glucose homeostasis in short non-growth hormone-deficient small-for-gestational-age children: results from a two-year controlled prospective study.
    Audí L; Carrascosa A; Esteban C; Fernández-Cancio M; Andaluz P; Yeste D; Espadero R; Granada ML; Wollmann H; Fryklund L;
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2709-15. PubMed ID: 18445665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary pyridinium collagen cross-links predict growth performance in children with idiopathic short stature and with growth hormone (GH) deficiency treated with GH. Skeletal metabolism during GH treatment.
    Spagnoli A; Branca F; Spadoni GL; Cianfarani S; Pasquino AM; Argirò G; Vitale S; Robins SP; Boscherini B
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3589-93. PubMed ID: 8855806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of growth hormone therapy on glucose metabolism and insulin sensitivity indices in prepubertal children with Prader-Willi syndrome.
    Crinò A; Di Giorgio G; Manco M; Grugni G; Maggioni A
    Horm Res; 2007; 68(2):83-90. PubMed ID: 17337902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of growth hormone therapy on metabolic parameters, adipokine and endothelial dysfunction in prepuberal children.
    Cañete MD; Valle-Martos R; Martos R; Cañete R; Valle M; Jiménez-Reina L
    Acta Paediatr; 2019 Nov; 108(11):2027-2033. PubMed ID: 31087421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of growth hormone treatment on metabolic and cardiovascular risk factors is similar in preterm and term short, small for gestational age children.
    de Kort SW; Willemsen RH; van der Kaay DC; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2009 Jul; 71(1):65-73. PubMed ID: 19094073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum homocysteine concentrations in children with growth hormone (GH) deficiency before and after 12 months GH replacement.
    Esposito V; Di Biase S; Lettiero T; Labella D; Simeone R; Salerno M
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):607-11. PubMed ID: 15521964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W; Briody J; Moore B; Lu PW; Cowell CT
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
    Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of glucose and lipid metabolism and bone mineralization in patients with growth hormone deficiency with and without long-term growth hormone replacement.
    Roemmler J; Kuenkler M; Schneider HJ; Dieterle C; Schopohl J
    Metabolism; 2010 Mar; 59(3):350-8. PubMed ID: 19800640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.